These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1986724)
21. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Crowson AN; Magro CM Hum Pathol; 1996 Jan; 27(1):15-9. PubMed ID: 8543305 [TBL] [Abstract][Full Text] [Related]
22. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis? Wargula JC; Lovell DJ; Passo MH; Bove KE; Santangelo JD; Levinson JE Clin Exp Rheumatol; 2006; 24(3):333-43. PubMed ID: 16870106 [TBL] [Abstract][Full Text] [Related]
23. Relationship between capillary and muscle damage in dermatomyositis. Casademont J; Grau JM; Estruch R; Pedro-Botet JC; Urbano-Márquez A Int J Dermatol; 1990 Mar; 29(2):117-20. PubMed ID: 2323864 [TBL] [Abstract][Full Text] [Related]
24. [The clinical and muscular pathological study of dermatomyositis with perifascicular atrophy changes]. Liu Z; Chen L; Guo YP; Ren HT; Zhao YH Zhonghua Nei Ke Za Zhi; 2012 Sep; 51(9):698-701. PubMed ID: 23158920 [TBL] [Abstract][Full Text] [Related]
25. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis. Jain A; Sharma MC; Sarkar C; Bhatia R; Singh S; Gulati S; Handa R Acta Neurol Scand; 2011 Feb; 123(2):122-9. PubMed ID: 20497129 [TBL] [Abstract][Full Text] [Related]
26. Terbinafine-induced dermatomyositis: a case report and literature review of drug-induced dermatomyositis. Magro CM; Schaefer JT; Waldman J; Knight D; Seilstad K; Hearne D J Cutan Pathol; 2008 Jan; 35(1):74-81. PubMed ID: 18096000 [TBL] [Abstract][Full Text] [Related]
30. Ultrastructural abnormalities and perifascicular atrophy in childhood dermatomyositis with special reference to transverse tubular system-sarcoplasmic reticulum junctions. Chou SM; Miike T Arch Pathol Lab Med; 1981 Feb; 105(2):76-85. PubMed ID: 6893922 [TBL] [Abstract][Full Text] [Related]
31. [Immunopathological changes of micro-vessels in dermatomyositis]. Shen GL; Lü H; Bi HY; Zhang W; Yao S; Tu P; Yuan Y Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(27):1912-5. PubMed ID: 17064530 [TBL] [Abstract][Full Text] [Related]
32. Myositis in mixed connective tissue disease: a unique syndrome characterized by immunohistopathologic elements of both polymyositis and dermatomyositis. Vianna MA; Borges CT; Borba EF; Caleiro MT; Bonfá E; Marie SK Arq Neuropsiquiatr; 2004 Dec; 62(4):923-34. PubMed ID: 15608947 [TBL] [Abstract][Full Text] [Related]
33. [Dermatomyositis]. Stoltenburg-Didinger G; Genth E Z Rheumatol; 2009 Jun; 68(4):287-94. PubMed ID: 19330338 [TBL] [Abstract][Full Text] [Related]
34. [Complement activation products (C3a and C5b-9) as markers of activity of dermatomyositis. Comparison with usual biochemical parameters]. Campo A; Hausmann G; Martí RM; Estrach T; Grau JM; Porcel JM; Herrero C Actas Dermosifiliogr; 2007; 98(6):403-14. PubMed ID: 17663930 [TBL] [Abstract][Full Text] [Related]
35. [Ultrastructure of skeletal muscles in children with dermatomyositis]. Sekamova SM; Kon'eva TN; Zhvaniia MA Arkh Patol; 1978; 40(2):56-65. PubMed ID: 646665 [TBL] [Abstract][Full Text] [Related]
36. Small blood vessel involvement in childhood dermatomyositis. An ultrastructural study of a case. Ludatscher R; Gellei B; Guershoni G; Benderley A Isr J Med Sci; 1977 Jan; 13(1):20-5. PubMed ID: 838568 [TBL] [Abstract][Full Text] [Related]